Granted Patent
Utility
US 6,121,000 · App. 09/249,730
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
Inventors:
Jim A. Wright, Aiping H. Young
Patented Case
View Patent ↗
Granted: Sep 19, 2000
Filed: Feb 11, 1999
Inventors
Jim A. Wright
Aiping H. Young
Assignee (at issue)
Genesense Technologies Inc.
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.